APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Favipiravir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Favipiravir Industry Growth and Trends Forecast to 2032

Report ID 173991030128 December 202592 pages

Choose your research edition.

Industry ResearchFavipiravir Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Favipiravir Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Favipiravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Favipiravir Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Favipiravir Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Favipiravir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Favipiravir include ChemRar Group, Cipla, Dr. Reddy, Fujifilm, Glenmark, Lupin, R-Pharma, Sun Pharma and Hisun Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Favipiravir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Favipiravir market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Favipiravir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Favipiravir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Favipiravir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Favipiravir Market by Company

ChemRar Group

Cipla

Dr. Reddy

Fujifilm

Glenmark

Lupin

R-Pharma

Sun Pharma

Hisun Pharm

Favipiravir Segment by Type

Brand Drug

Generic Drug

Favipiravir Segment by Application

Influenza Viruses

COVID-19

Others

Favipiravir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Favipiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Favipiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Favipiravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Favipiravir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Favipiravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Brand Drug Table 2. Major Company of Generic Drug Table 3. Global Favipiravir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 5. Global Favipiravir Sales Market Share in Volume by Type (2021-2026) Table 6. Global Favipiravir Sales by Type (2021-2026) & (US$ Million) Table 7. Global Favipiravir Sales Market Share in Value by Type (2021-2026) Table 8. Global Favipiravir Price by Type (2021-2026) & (US$/Pcs) Table 9. Global Favipiravir Sales by Type (2027-2032) & (K Pcs) Table 10. Global Favipiravir Sales Market Share in Volume by Type (2027-2032) Table 11. Global Favipiravir Sales by Type (2027-2032) & (US$ Million) Table 12. Global Favipiravir Sales Market Share in Value by Type (2027-2032) Table 13. Global Favipiravir Price by Type (2027-2032) & (US$/Pcs) Table 14. North America Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 15. North America Favipiravir Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 17. Europe Favipiravir Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 19. Asia-Pacific Favipiravir Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 21. Latin America Favipiravir Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 23. Middle East and Africa Favipiravir Sales by Type (2021-2026) & (US$ Million) Table 24. Favipiravir Industry Trends Table 25. Favipiravir Industry Drivers Table 26. Favipiravir Industry Opportunities and Challenges Table 27. Favipiravir Industry Restraints Table 28. Global Favipiravir Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Favipiravir Revenue Market Share by Company (2021-2026) Table 30. Global Favipiravir Sales by Company (2021-2026) & (K Pcs) Table 31. Global Favipiravir Sales Share by Company (2021-2026) Table 32. Global Favipiravir Market Price by Company (2021-2026) & (US$/Pcs) Table 33. Global Favipiravir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Favipiravir Major Company Production Sites and Headquarters Table 35. Global Favipiravir Company, Product Type & Application Table 36. Global Favipiravir Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Favipiravir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Favipiravir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Favipiravir Sales by Region (2021-2026) & (K Pcs) Table 41. Global Favipiravir Sales Market Share in Volume by Region (2021-2026) Table 42. Global Favipiravir Sales by Region (2021-2026) & (US$ Million) Table 43. Global Favipiravir Sales Market Share in Value by Region (2021-2026) Table 44. Global Favipiravir Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 45. Global Favipiravir Sales by Region (2027-2032) & (K Pcs) Table 46. Global Favipiravir Sales Market Share in Volume by Region (2027-2032) Table 47. Global Favipiravir Sales by Region (2027-2032) & (US$ Million) Table 48. Global Favipiravir Sales Market Share in Value by Region (2027-2032) Table 49. Global Favipiravir Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 50. Global Favipiravir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 52. Global Favipiravir Sales Market Share in Volume by Application (2021-2026) Table 53. Global Favipiravir Sales by Application (2021-2026) & (US$ Million) Table 54. Global Favipiravir Sales Market Share in Value by Application (2021-2026) Table 55. Global Favipiravir Price by Application (2021-2026) & (US$/Pcs) Table 56. Global Favipiravir Sales by Application (2027-2032) & (K Pcs) Table 57. Global Favipiravir Sales Market Share in Volume by Application (2027-2032) Table 58. Global Favipiravir Sales by Application (2027-2032) & (US$ Million) Table 59. Global Favipiravir Sales Market Share in Value by Application (2027-2032) Table 60. Global Favipiravir Price by Application (2027-2032) & (US$/Pcs) Table 61. North America Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 62. North America Favipiravir Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 64. Europe Favipiravir Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 66. Asia-Pacific Favipiravir Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 68. Latin America Favipiravir Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 70. Middle East and Africa Favipiravir Sales by Application (2021-2026) & (US$ Million) Table 71. ChemRar Group Company Information Table 72. ChemRar Group Business Overview Table 73. ChemRar Group Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 74. ChemRar Group Favipiravir Product Portfolio Table 75. ChemRar Group Recent Development Table 76. Cipla Company Information Table 77. Cipla Business Overview Table 78. Cipla Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 79. Cipla Favipiravir Product Portfolio Table 80. Cipla Recent Development Table 81. Dr. Reddy Company Information Table 82. Dr. Reddy Business Overview Table 83. Dr. Reddy Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 84. Dr. Reddy Favipiravir Product Portfolio Table 85. Dr. Reddy Recent Development Table 86. Fujifilm Company Information Table 87. Fujifilm Business Overview Table 88. Fujifilm Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 89. Fujifilm Favipiravir Product Portfolio Table 90. Fujifilm Recent Development Table 91. Glenmark Company Information Table 92. Glenmark Business Overview Table 93. Glenmark Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 94. Glenmark Favipiravir Product Portfolio Table 95. Glenmark Recent Development Table 96. Lupin Company Information Table 97. Lupin Business Overview Table 98. Lupin Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 99. Lupin Favipiravir Product Portfolio Table 100. Lupin Recent Development Table 101. R-Pharma Company Information Table 102. R-Pharma Business Overview Table 103. R-Pharma Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 104. R-Pharma Favipiravir Product Portfolio Table 105. R-Pharma Recent Development Table 106. Sun Pharma Company Information Table 107. Sun Pharma Business Overview Table 108. Sun Pharma Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 109. Sun Pharma Favipiravir Product Portfolio Table 110. Sun Pharma Recent Development Table 111. Hisun Pharm Company Information Table 112. Hisun Pharm Business Overview Table 113. Hisun Pharm Favipiravir Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 114. Hisun Pharm Favipiravir Product Portfolio Table 115. Hisun Pharm Recent Development Table 116. North America Favipiravir Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 117. North America Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 118. North America Favipiravir Sales Market Share by Country (2021-2026) Table 119. North America Favipiravir Sales Forecast by Country (2027-2032) & (K Pcs) Table 120. North America Favipiravir Sales Market Share Forecast by Country (2027-2032) Table 121. North America Favipiravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Favipiravir Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Favipiravir Market Share by Country (2021-2026) Table 124. North America Favipiravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Favipiravir Market Share Forecast by Country (2027-2032) Table 126. Europe Favipiravir Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 127. Europe Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 128. Europe Favipiravir Sales Market Share by Country (2021-2026) Table 129. Europe Favipiravir Sales Forecast by Country (2027-2032) & (K Pcs) Table 130. Europe Favipiravir Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Favipiravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Favipiravir Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Favipiravir Market Share by Country (2021-2026) Table 134. Europe Favipiravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Favipiravir Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Favipiravir Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 138. Asia-Pacific Favipiravir Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Favipiravir Sales Forecast by Country (2027-2032) & (K Pcs) Table 140. Asia-Pacific Favipiravir Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Favipiravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Favipiravir Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Favipiravir Market Share by Country (2021-2026) Table 144. Asia-Pacific Favipiravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Favipiravir Market Share Forecast by Country (2027-2032) Table 146. Latin America Favipiravir Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 147. Latin America Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 148. Latin America Favipiravir Sales Market Share by Country (2021-2026) Table 149. Latin America Favipiravir Sales Forecast by Country (2027-2032) & (K Pcs) Table 150. Latin America Favipiravir Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Favipiravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Favipiravir Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Favipiravir Market Share by Country (2021-2026) Table 154. Latin America Favipiravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Favipiravir Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Favipiravir Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 158. Middle East and Africa Favipiravir Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Favipiravir Sales Forecast by Country (2027-2032) & (K Pcs) Table 160. Middle East and Africa Favipiravir Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Favipiravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Favipiravir Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Favipiravir Market Share by Country (2021-2026) Table 164. Middle East and Africa Favipiravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Favipiravir Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Favipiravir Distributors List Table 169. Favipiravir Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Favipiravir Image Figure 2. Global Favipiravir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Favipiravir Market Size (2021-2032) & (US$ Million) Figure 4. Global Favipiravir Sales (2021-2032) & (K Pcs) Figure 5. Brand Drug Image Figure 6. Global Brand Drug Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Global Favipiravir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Favipiravir Market Share by Type 2025 VS 2032 Figure 11. North America Favipiravir Sales Market Share in Volume by Type in 2025 Figure 12. North America Favipiravir Sales Market Share in Value by Type in 2025 Figure 13. Europe Favipiravir Sales Market Share in Volume by Type in 2025 Figure 14. Europe Favipiravir Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Favipiravir Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Favipiravir Sales Market Share in Value by Type in 2025 Figure 17. Latin America Favipiravir Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Favipiravir Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Favipiravir Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Favipiravir Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Favipiravir Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Influenza Viruses Image Figure 24. Global Influenza Viruses Sales YoY Growth (2021-2032) & (K Pcs) Figure 25. COVID-19 Image Figure 26. Global COVID-19 Sales YoY Growth (2021-2032) & (K Pcs) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Global Favipiravir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Favipiravir Market Share by Application 2025 VS 2032 Figure 31. North America Favipiravir Sales Market Share in Volume by Application in 2025 Figure 32. North America Favipiravir Sales Market Share in Value by Application in 2025 Figure 33. Europe Favipiravir Sales Market Share in Volume by Application in 2025 Figure 34. Europe Favipiravir Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Favipiravir Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Favipiravir Sales Market Share in Value by Application in 2025 Figure 37. Latin America Favipiravir Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Favipiravir Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Favipiravir Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Favipiravir Sales Market Share in Value by Application in 2025 Figure 41. North America Favipiravir Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 42. North America Favipiravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Favipiravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Favipiravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Favipiravir Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. Europe Favipiravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Favipiravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Favipiravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Favipiravir Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Asia-Pacific Favipiravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Favipiravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Favipiravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Favipiravir Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Latin America Favipiravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Favipiravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Favipiravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Favipiravir Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Middle East and Africa Favipiravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Favipiravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Favipiravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Favipiravir Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Favipiravir Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Influenza Viruses
  • COVID-19
  • Others
Companies covered
  • ChemRar Group
  • Cipla
  • Dr. Reddy
  • Fujifilm
  • Glenmark
  • Lupin
  • R-Pharma
  • Sun Pharma
  • Hisun Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Favipiravir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Favipiravir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Favipiravir Market by Type
  6. 1.3.1 Brand Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Favipiravir Market Size by Type
  9. 1.4.1 Global Favipiravir Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Favipiravir Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Favipiravir Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Favipiravir Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Favipiravir Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Favipiravir Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Favipiravir Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Favipiravir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Favipiravir Industry Trends
  2. 2.2 Favipiravir Industry Drivers
  3. 2.3 Favipiravir Industry Opportunities and Challenges
  4. 2.4 Favipiravir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Favipiravir Revenue (2021-2026)
  2. 3.2 Global Top Players by Favipiravir Sales (2021-2026)
  3. 3.3 Global Top Players by Favipiravir Price (2021-2026)
  4. 3.4 Global Favipiravir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Favipiravir Major Company Production Sites & Headquarters
  6. 3.6 Global Favipiravir Company, Product Type & Application
  7. 3.7 Global Favipiravir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Favipiravir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Favipiravir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Favipiravir Tier 1, Tier 2, and Tier 3
4 Favipiravir Regional Status and Outlook
  1. 4.1 Global Favipiravir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Favipiravir Historic Market Size by Region
  3. 4.2.1 Global Favipiravir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Favipiravir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Favipiravir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Favipiravir Forecasted Market Size by Region
  7. 4.3.1 Global Favipiravir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Favipiravir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Favipiravir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Favipiravir by Application
  1. 5.1 Favipiravir Market by Application
  2. 5.1.1 Influenza Viruses
  3. 5.1.2 COVID-19
  4. 5.1.3 Others
  5. 5.2 Global Favipiravir Market Size by Application
  6. 5.2.1 Global Favipiravir Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Favipiravir Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Favipiravir Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Favipiravir Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Favipiravir Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Favipiravir Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Favipiravir Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Favipiravir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ChemRar Group
  2. 6.1.1 ChemRar Group Company Information
  3. 6.1.2 ChemRar Group Business Overview
  4. 6.1.3 ChemRar Group Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ChemRar Group Favipiravir Product Portfolio
  6. 6.1.5 ChemRar Group Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Favipiravir Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Dr. Reddy
  14. 6.3.1 Dr. Reddy Company Information
  15. 6.3.2 Dr. Reddy Business Overview
  16. 6.3.3 Dr. Reddy Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. Reddy Favipiravir Product Portfolio
  18. 6.3.5 Dr. Reddy Recent Developments
  19. 6.4 Fujifilm
  20. 6.4.1 Fujifilm Company Information
  21. 6.4.2 Fujifilm Business Overview
  22. 6.4.3 Fujifilm Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fujifilm Favipiravir Product Portfolio
  24. 6.4.5 Fujifilm Recent Developments
  25. 6.5 Glenmark
  26. 6.5.1 Glenmark Company Information
  27. 6.5.2 Glenmark Business Overview
  28. 6.5.3 Glenmark Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Glenmark Favipiravir Product Portfolio
  30. 6.5.5 Glenmark Recent Developments
  31. 6.6 Lupin
  32. 6.6.1 Lupin Company Information
  33. 6.6.2 Lupin Business Overview
  34. 6.6.3 Lupin Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lupin Favipiravir Product Portfolio
  36. 6.6.5 Lupin Recent Developments
  37. 6.7 R-Pharma
  38. 6.7.1 R-Pharma Company Information
  39. 6.7.2 R-Pharma Business Overview
  40. 6.7.3 R-Pharma Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 R-Pharma Favipiravir Product Portfolio
  42. 6.7.5 R-Pharma Recent Developments
  43. 6.8 Sun Pharma
  44. 6.8.1 Sun Pharma Company Information
  45. 6.8.2 Sun Pharma Business Overview
  46. 6.8.3 Sun Pharma Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharma Favipiravir Product Portfolio
  48. 6.8.5 Sun Pharma Recent Developments
  49. 6.9 Hisun Pharm
  50. 6.9.1 Hisun Pharm Company Information
  51. 6.9.2 Hisun Pharm Business Overview
  52. 6.9.3 Hisun Pharm Favipiravir Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hisun Pharm Favipiravir Product Portfolio
  54. 6.9.5 Hisun Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Favipiravir Sales by Country
  2. 7.1.1 North America Favipiravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Favipiravir Sales by Country (2021-2026)
  4. 7.1.3 North America Favipiravir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Favipiravir Market Size by Country
  6. 7.2.1 North America Favipiravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Favipiravir Market Size by Country (2021-2026)
  8. 7.2.3 North America Favipiravir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Favipiravir Sales by Country
  2. 8.1.1 Europe Favipiravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Favipiravir Sales by Country (2021-2026)
  4. 8.1.3 Europe Favipiravir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Favipiravir Market Size by Country
  6. 8.2.1 Europe Favipiravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Favipiravir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Favipiravir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Favipiravir Sales by Country
  2. 9.1.1 Asia-Pacific Favipiravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Favipiravir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Favipiravir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Favipiravir Market Size by Country
  6. 9.2.1 Asia-Pacific Favipiravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Favipiravir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Favipiravir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Favipiravir Sales by Country
  2. 10.1.1 South America Favipiravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Favipiravir Sales by Country (2021-2026)
  4. 10.1.3 South America Favipiravir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Favipiravir Market Size by Country
  6. 10.2.1 South America Favipiravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Favipiravir Market Size by Country (2021-2026)
  8. 10.2.3 South America Favipiravir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Favipiravir Sales by Country
  2. 11.1.1 Middle East and Africa Favipiravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Favipiravir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Favipiravir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Favipiravir Market Size by Country
  6. 11.2.1 Middle East and Africa Favipiravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Favipiravir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Favipiravir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Favipiravir Value Chain Analysis
  2. 12.1.1 Favipiravir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Favipiravir Production Mode & Process
  7. 12.2 Favipiravir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Favipiravir Distributors
  10. 12.2.3 Favipiravir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst